{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T17:53:39Z","timestamp":1769018019428,"version":"3.49.0"},"reference-count":59,"publisher":"The Endocrine Society","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,5,1]]},"DOI":"10.1210\/en.2016-1825","type":"journal-article","created":{"date-parts":[[2017,4,19]],"date-time":"2017-04-19T15:26:06Z","timestamp":1492615566000},"page":"1298-1313","source":"Crossref","is-referenced-by-count":11,"title":["A Selective Bombesin Receptor Subtype 3 Agonist Promotes Weight Loss in Male Diet-Induced\u2013Obese Rats With Circadian Rhythm Change"],"prefix":"10.1210","volume":"158","author":[{"given":"Yasunori","family":"Nio","sequence":"first","affiliation":[{"name":"Extra Value Generation & General Medicine Drug Discovery Unit, Takeda Pharmaceutical Company Ltd, Fujisawa, Kanagawa 251-8555, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natsu","family":"Hotta","sequence":"additional","affiliation":[{"name":"Cardiovascular and Metabolic Drug Discovery Unit, Takeda Pharmaceutical Company Ltd, Fujisawa, Kanagawa 251-8555, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minoru","family":"Maruyama","sequence":"additional","affiliation":[{"name":"Cardiovascular and Metabolic Drug Discovery Unit, Takeda Pharmaceutical Company Ltd, Fujisawa, Kanagawa 251-8555, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenichi","family":"Hamagami","sequence":"additional","affiliation":[{"name":"Cardiovascular and Metabolic Drug Discovery Unit, Takeda Pharmaceutical Company Ltd, Fujisawa, Kanagawa 251-8555, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshimi","family":"Nagi","sequence":"additional","affiliation":[{"name":"Central Nervous System Drug Discovery Unit, Takeda Pharmaceutical Company Ltd, Fujisawa, Kanagawa 251-8555, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaaki","family":"Funata","sequence":"additional","affiliation":[{"name":"Biomolecular Research Laboratories, Takeda Pharmaceutical Company Ltd, Fujisawa, Kanagawa 251-8555, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junichi","family":"Sakamoto","sequence":"additional","affiliation":[{"name":"Biomolecular Research Laboratories, Takeda Pharmaceutical Company Ltd, Fujisawa, Kanagawa 251-8555, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masanori","family":"Nakakariya","sequence":"additional","affiliation":[{"name":"Drug Metabolism and Pharmacokinetics Research Laboratories, Takeda Pharmaceutical Company Ltd, Fujisawa, Kanagawa 251-8555, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuyuki","family":"Amano","sequence":"additional","affiliation":[{"name":"Drug Metabolism and Pharmacokinetics Research Laboratories, Takeda Pharmaceutical Company Ltd, Fujisawa, Kanagawa 251-8555, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohiro","family":"Okawa","sequence":"additional","affiliation":[{"name":"Central Nervous System Drug Discovery Unit, Takeda Pharmaceutical Company Ltd, Fujisawa, Kanagawa 251-8555, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuyoshi","family":"Arikawa","sequence":"additional","affiliation":[{"name":"Central Nervous System Drug Discovery Unit, Takeda Pharmaceutical Company Ltd, Fujisawa, Kanagawa 251-8555, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinobu","family":"Sasaki","sequence":"additional","affiliation":[{"name":"Medicinal Chemistry Research Laboratories, Pharmaceutical Research Division, Takeda Pharmaceutical Company Ltd, Fujisawa, Kanagawa 251-8555, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shoki","family":"Okuda","sequence":"additional","affiliation":[{"name":"Cardiovascular and Metabolic Drug Discovery Unit, Takeda Pharmaceutical Company Ltd, Fujisawa, Kanagawa 251-8555, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shizuo","family":"Kasai","sequence":"additional","affiliation":[{"name":"Cardiovascular and Metabolic Drug Discovery Unit, Takeda Pharmaceutical Company Ltd, Fujisawa, Kanagawa 251-8555, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yugo","family":"Habata","sequence":"additional","affiliation":[{"name":"Foods & Nutrients, Yamanashi Gakuin Junior College, Kofu, Yamanashi 400-8575, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasutaka","family":"Nagisa","sequence":"additional","affiliation":[{"name":"CVM Marketing Japan Pharma Business Unit, Takeda Pharmaceutical Company Ltd, Chuo-ku, Tokyo 103-8686, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"80","published-online":{"date-parts":[[2017,3,16]]},"reference":[{"issue":"6","key":"2019041121281370000_B1","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3810\/pgm.2009.11.2074","article-title":"The medical risks of obesity","volume":"121","author":"Pi-Sunyer","year":"2009","journal-title":"Postgrad Med"},{"key":"2019041121281370000_B2","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/1471-2458-9-88","article-title":"The incidence of co-morbidities related to obesity and overweight: a systematic review and meta-analysis","volume":"9","author":"Guh","year":"2009","journal-title":"BMC Public Health"},{"issue":"6","key":"2019041121281370000_B3","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1007\/s11894-014-0394-0","article-title":"New pharmacological treatments for the management of obesity","volume":"16","author":"Hurt","year":"2014","journal-title":"Curr Gastroenterol Rep"},{"issue":"5","key":"2019041121281370000_B4","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1097\/01.med.0000433059.78485.fa","article-title":"New medications for obesity management: changing the landscape of obesity treatment","volume":"20","author":"Boulghassoul-Pietrzykowska","year":"2013","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"issue":"2","key":"2019041121281370000_B5","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1210\/jc.2014-3415","article-title":"Pharmacological management of obesity: an endocrine Society clinical practice guideline","volume":"100","author":"Apovian","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2019041121281370000_B6","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1001\/jama.2013.281361","article-title":"Long-term drug treatment for obesity: a systematic and clinical review","volume":"311","author":"Yanovski","year":"2014","journal-title":"JAMA"},{"issue":"7","key":"2019041121281370000_B7","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1038\/hr.2016.12","article-title":"A role for circadian clock in metabolic disease","volume":"39","author":"Shimizu","year":"2016","journal-title":"Hypertens Res"},{"issue":"5","key":"2019041121281370000_B8","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1038\/ijo.2014.201","article-title":"Social jetlag, obesity and metabolic disorder: investigation in a cohort study","volume":"39","author":"Parsons","year":"2015","journal-title":"Int J Obes"},{"issue":"5","key":"2019041121281370000_B9","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.tem.2009.12.011","article-title":"Interactions of the circadian CLOCK system and the HPA axis","volume":"21","author":"Nader","year":"2010","journal-title":"Trends Endocrinol Metab"},{"issue":"6","key":"2019041121281370000_B10","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1177\/0748730406293854","article-title":"SCN outputs and the hypothalamic balance of life","volume":"21","author":"Kalsbeek","year":"2006","journal-title":"J Biol Rhythms"},{"issue":"10","key":"2019041121281370000_B11","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1038\/nrg2430","article-title":"The genetics of mammalian circadian order and disorder: implications for physiology and disease","volume":"9","author":"Takahashi","year":"2008","journal-title":"Nat Rev Genet"},{"issue":"2","key":"2019041121281370000_B12","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.cmet.2006.07.002","article-title":"The circadian rhythm of glucocorticoids is regulated by a gating mechanism residing in the adrenal cortical clock","volume":"4","author":"Oster","year":"2006","journal-title":"Cell Metab"},{"issue":"2","key":"2019041121281370000_B13","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1677\/JOE-07-0378","article-title":"Circadian clocks: regulators of endocrine and metabolic rhythms","volume":"195","author":"Hastings","year":"2007","journal-title":"J Endocrinol"},{"issue":"1688","key":"2019041121281370000_B14","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1098\/rspb.2009.2148","article-title":"Origin of ultradian pulsatility in the hypothalamic-pituitary-adrenal axis","volume":"277","author":"Walker","year":"2010","journal-title":"Proc Biol Sci"},{"issue":"20","key":"2019041121281370000_B15","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1056\/NEJM199505183322008","article-title":"The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation","volume":"332","author":"Chrousos","year":"1995","journal-title":"N Engl J Med"},{"issue":"6","key":"2019041121281370000_B16","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/nrn1683","article-title":"Stress and the brain: from adaptation to disease","volume":"6","author":"de Kloet","year":"2005","journal-title":"Nat Rev Neurosci"},{"issue":"6","key":"2019041121281370000_B17","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1007\/s00424-011-1022-6","article-title":"How mental stress affects endothelial function","volume":"462","author":"Toda","year":"2011","journal-title":"Pflugers Arch"},{"issue":"5488","key":"2019041121281370000_B18","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1126\/science.289.5488.2344","article-title":"Resetting of circadian time in peripheral tissues by glucocorticoid signaling","volume":"289","author":"Balsalobre","year":"2000","journal-title":"Science"},{"issue":"6","key":"2019041121281370000_B19","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1177\/0748730405279866","article-title":"Glucocorticoid administration increases hPer1 mRNA levels in human peripheral blood mononuclear cells in vitro or in vivo","volume":"20","author":"Fukuoka","year":"2005","journal-title":"J Biol Rhythms"},{"issue":"2","key":"2019041121281370000_B20","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1254\/jphs.FMJ06003X4","article-title":"Circadian rhythms in the CNS and peripheral clock disorders: function of clock genes: influence of medication for bronchial asthma on circadian gene","volume":"103","author":"Burioka","year":"2007","journal-title":"J Pharmacol Sci"},{"issue":"28","key":"2019041121281370000_B21","doi-asserted-by":"crossref","first-page":"18771","DOI":"10.1016\/S0021-9258(18)55129-2","article-title":"Two distinct bombesin receptor subtypes are expressed and functional in human lung carcinoma cells","volume":"266","author":"Corjay","year":"1991","journal-title":"J Biol Chem"},{"issue":"22","key":"2019041121281370000_B22","doi-asserted-by":"crossref","first-page":"13613","DOI":"10.1074\/jbc.273.22.13613","article-title":"Ability of various bombesin receptor agonists and antagonists to alter intracellular signaling of the human orphan receptor BRS-3","volume":"273","author":"Ryan","year":"1998","journal-title":"J Biol Chem"},{"issue":"12","key":"2019041121281370000_B23","doi-asserted-by":"crossref","first-page":"9219","DOI":"10.1074\/jbc.M008737200","article-title":"Rational design of a peptide agonist that interacts selectively with the orphan receptor, bombesin receptor subtype 3","volume":"276","author":"Mantey","year":"2001","journal-title":"J Biol Chem"},{"issue":"6656","key":"2019041121281370000_B24","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/36568","article-title":"Mice lacking bombesin receptor subtype-3 develop metabolic defects and obesity","volume":"390","author":"Ohki-Hamazaki","year":"1997","journal-title":"Nature"},{"issue":"1","key":"2019041121281370000_B25","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/sj.mp.4000974","article-title":"Role of bombesin (BN)-like peptides\/receptors in emotional behavior by comparison of three strains of BN-like peptide receptor knockout mice","volume":"7","author":"Yamada","year":"2002","journal-title":"Mol Psychiatry"},{"issue":"3","key":"2019041121281370000_B26","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1210\/en.2007-1319","article-title":"Factors contributing to obesity in bombesin receptor subtype-3-deficient mice","volume":"149","author":"Ladenheim","year":"2008","journal-title":"Endocrinology"},{"key":"2019041121281370000_B27","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.cmet.2009.12.008","article-title":"Regulation of energy homeostasis by bombesin receptor subtype-3: selective receptor agonists for the treatment of obesity","volume":"11","author":"Guan","year":"2010","journal-title":"Cell Metab"},{"issue":"2","key":"2019041121281370000_B28","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1124\/jpet.110.174763","article-title":"Antiobesity effect of MK-5046, a novel bombesin receptor subtype-3 agonist","volume":"336","author":"Guan","year":"2011","journal-title":"J Pharmacol Exp Ther"},{"issue":"9","key":"2019041121281370000_B29","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1177\/0091270011419854","article-title":"Pharmacokinetics and pharmacodynamics of MK-5046, a bombesin receptor subtype-3 (BRS-3) agonist, in healthy patients","volume":"52","author":"Reitman","year":"2012","journal-title":"J Clin Pharmacol"},{"issue":"7","key":"2019041121281370000_B30","doi-asserted-by":"crossref","first-page":"H891","DOI":"10.1152\/ajpheart.00963.2015","article-title":"Bombesin-like receptor 3 regulates blood pressure and heart rate via a central sympathetic mechanism","volume":"310","author":"Lateef","year":"2016","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"2","key":"2019041121281370000_B31","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0306-4522(03)00260-4","article-title":"The distribution of the orphan bombesin receptor subtype-3 in the rat CNS","volume":"120","author":"Jennings","year":"2003","journal-title":"Neuroscience"},{"issue":"1","key":"2019041121281370000_B32","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ygeno.2004.01.008","article-title":"Characterization of the bombesin-like peptide receptor family in primates","volume":"84","author":"Sano","year":"2004","journal-title":"Genomics"},{"issue":"5","key":"2019041121281370000_B33","doi-asserted-by":"crossref","first-page":"e37833","DOI":"10.1371\/journal.pone.0037833","article-title":"Integrative gene regulatory network analysis reveals light-induced regional gene expression phase shift programs in the mouse suprachiasmatic nucleus","volume":"7","author":"Zhu","year":"2012","journal-title":"PLoS One"},{"issue":"4","key":"2019041121281370000_B34","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.cub.2011.12.051","article-title":"Disrupted circadian rhythms in a mouse model of schizophrenia","volume":"22","author":"Oliver","year":"2012","journal-title":"Curr Biol"},{"issue":"9","key":"2019041121281370000_B35","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1038\/oby.2003.152","article-title":"Effect of sibutramine on weight loss and blood pressure: a meta-analysis of controlled trials","volume":"11","author":"Kim","year":"2003","journal-title":"Obes Res"},{"issue":"5","key":"2019041121281370000_B36","doi-asserted-by":"crossref","first-page":"E816","DOI":"10.1152\/ajpendo.00404.2010","article-title":"Body temperature as a mouse pharmacodynamic response to bombesin receptor subtype-3 agonists and other potential obesity treatments","volume":"299","author":"Metzger","year":"2010","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"2","key":"2019041121281370000_B37","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1002\/syn.21789","article-title":"Enhancement of 18F-fluorodeoxyglucose metabolism in rat brain frontal cortex using a \u03b23 adrenoceptor agonist","volume":"69","author":"Mirbolooki","year":"2015","journal-title":"Synapse"},{"issue":"41","key":"2019041121281370000_B38","doi-asserted-by":"crossref","first-page":"26062","DOI":"10.1074\/jbc.272.41.26062","article-title":"Discovery of a high affinity radioligand for the human orphan receptor, bombesin receptor subtype 3, which demonstrates that it has a unique pharmacology compared with other mammalian bombesin receptors","volume":"272","author":"Mantey","year":"1997","journal-title":"J Biol Chem"},{"issue":"15","key":"2019041121281370000_B39","doi-asserted-by":"crossref","first-page":"4544","DOI":"10.1016\/j.bmc.2015.06.003","article-title":"Optimization of a novel series of N-phenylindoline-5-sulfonamide-based acyl CoA:monoacylglycerol acyltransferase-2 inhibitors: Mitigation of CYP3A4 time-dependent inhibition and phototoxic liabilities","volume":"23","author":"Sato","year":"2015","journal-title":"Bioorg Med Chem"},{"issue":"4","key":"2019041121281370000_B40","doi-asserted-by":"crossref","first-page":"R1031","DOI":"10.1152\/ajpregu.90399.2008","article-title":"Relationships between circadian rhythms and modulation of gene expression by glucocorticoids in skeletal muscle","volume":"295","author":"Almon","year":"2008","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"1","key":"2019041121281370000_B41","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1161\/ATVBAHA.107.152538","article-title":"Peripheral circadian clock rhythmicity is retained in the absence of adrenergic signaling","volume":"28","author":"Reilly","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2019041121281370000_B42","doi-asserted-by":"crossref","first-page":"33500","DOI":"10.1038\/srep33500","article-title":"SCOP\/PHLPP1\u03b2 in the basolateral amygdala regulates circadian expression of mouse anxiety-like behavior","volume":"6","author":"Nakano","year":"2016","journal-title":"Sci Rep"},{"issue":"1-2","key":"2019041121281370000_B43","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3109\/07853890.2015.1122216","article-title":"Fluoxetine normalizes disrupted light-induced entrainment, fragmented ultradian rhythms and altered hippocampal clock gene expression in an animal model of high trait anxiety- and depression-related behavior","volume":"48","author":"Schaufler","year":"2016","journal-title":"Ann Med"},{"issue":"2","key":"2019041121281370000_B44","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/ejn.12010","article-title":"Circadian genes Period 1 and Period 2 in the nucleus accumbens regulate anxiety-related behavior","volume":"37","author":"Spencer","year":"2013","journal-title":"Eur J Neurosci"},{"issue":"7","key":"2019041121281370000_B45","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1038\/sj.bjp.0702957","article-title":"Modulation of mPer1 gene expression by anxiolytic drugs in mouse cerebellum","volume":"128","author":"Akiyama","year":"1999","journal-title":"Br J Pharmacol"},{"issue":"6 Pt 2","key":"2019041121281370000_B46","first-page":"H1354","article-title":"Role of mineralocorticoids and glucocorticoids in blood pressure regulation in normotensive rats","volume":"251","author":"Yagil","year":"1986","journal-title":"Am J Physiol"},{"issue":"3-4","key":"2019041121281370000_B47","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1159\/000181807","article-title":"Glucocorticoids in blood pressure regulation","volume":"34","author":"Gr\u00fcnfeld","year":"1990","journal-title":"Horm Res"},{"issue":"1","key":"2019041121281370000_B48","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1113\/expphysiol.2008.045971","article-title":"Regulation of the stress response in rats by central actions of glucocorticoids","volume":"95","author":"Scheuer","year":"2010","journal-title":"Exp Physiol"},{"issue":"2","key":"2019041121281370000_B49","doi-asserted-by":"crossref","first-page":"R212","DOI":"10.1152\/ajpregu.00326.2013","article-title":"Elevated corticosterone in the dorsal hindbrain increases plasma norepinephrine and neuropeptide Y, and recruits a vasopressin response to stress","volume":"307","author":"Daubert","year":"2014","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"5","key":"2019041121281370000_B50","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1210\/en.2011-1794","article-title":"Differential entrainment of peripheral clocks in the rat by glucocorticoid and feeding","volume":"153","author":"Sujino","year":"2012","journal-title":"Endocrinology"},{"issue":"51","key":"2019041121281370000_B51","doi-asserted-by":"crossref","first-page":"42036","DOI":"10.1074\/jbc.M509600200","article-title":"Acute physical stress elevates mouse period1 mRNA expression in mouse peripheral tissues via a glucocorticoid-responsive element","volume":"280","author":"Yamamoto","year":"2005","journal-title":"J Biol Chem"},{"issue":"6","key":"2019041121281370000_B52","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1002\/hep.21571","article-title":"Glucocorticoid signaling synchronizes the liver circadian transcriptome","volume":"45","author":"Reddy","year":"2007","journal-title":"Hepatology"},{"issue":"Pt 3","key":"2019041121281370000_B53","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1042\/BJ20041150","article-title":"CLOCK is involved in the circadian transactivation of peroxisome-proliferator-activated receptor alpha (PPARalpha) in mice","volume":"386","author":"Oishi","year":"2005","journal-title":"Biochem J"},{"issue":"1","key":"2019041121281370000_B54","doi-asserted-by":"crossref","first-page":"e84209","DOI":"10.1371\/journal.pone.0084209","article-title":"High fat diet and in utero exposure to maternal obesity disrupts circadian rhythm and leads to metabolic programming of liver in rat offspring","volume":"9","author":"Borengasser","year":"2014","journal-title":"PLoS One"},{"issue":"6 Pt 1","key":"2019041121281370000_B55","first-page":"E996","article-title":"Effects of morning rise in cortisol concentration on regulation of lipolysis in subcutaneous adipose tissue","volume":"271","author":"Samra","year":"1996","journal-title":"Am J Physiol"},{"issue":"11","key":"2019041121281370000_B56","doi-asserted-by":"crossref","first-page":"6795","DOI":"10.1073\/pnas.0936797100","article-title":"Adrenergic regulation of clock gene expression in mouse liver","volume":"100","author":"Terazono","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"issue":"7","key":"2019041121281370000_B57","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.2337\/db12-1449","article-title":"Circadian regulation of lipid mobilization in white adipose tissues","volume":"62","author":"Shostak","year":"2013","journal-title":"Diabetes"},{"issue":"4","key":"2019041121281370000_B58","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.cbpb.2012.04.005","article-title":"Effect of corticosterone on gene expression of feed intake regulatory peptides in laying hens","volume":"162","author":"Liu","year":"2012","journal-title":"Comp Biochem Physiol B Biochem Mol Biol"},{"issue":"1","key":"2019041121281370000_B59","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.bmc.2014.11.018","article-title":"Synthesis and biological evaluation of novel chiral diazepine derivatives as bombesin receptor subtype-3 (BRS-3) agonists incorporating an antedrug approach","volume":"23","author":"Matsufuji","year":"2015","journal-title":"Bioorg Med Chem"}],"container-title":["Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/endo\/article-pdf\/158\/5\/1298\/14068612\/en.2016-1825.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,27]],"date-time":"2022-07-27T17:34:08Z","timestamp":1658943248000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/endo\/article\/158\/5\/1298\/3072146"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,16]]},"references-count":59,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2017,3,16]]},"published-print":{"date-parts":[[2017,5,1]]}},"URL":"https:\/\/doi.org\/10.1210\/en.2016-1825","relation":{},"ISSN":["0013-7227","1945-7170"],"issn-type":[{"value":"0013-7227","type":"print"},{"value":"1945-7170","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2017,5,1]]},"published":{"date-parts":[[2017,3,16]]}}}